You write, "According to the Telegraph, the NHS will respond to the price increase by prescribing Mounjaro to more people."
I doubt very much that the NHS will "respond to" the price increase. But NICE is consulting on an update to its guidance for Type 2 diabetes, and its revised recommendations are likely to mean more people being prescribed GLP-1 agonists like Mounjaro.
You write, "According to the Telegraph, the NHS will respond to the price increase by prescribing Mounjaro to more people."
I doubt very much that the NHS will "respond to" the price increase. But NICE is consulting on an update to its guidance for Type 2 diabetes, and its revised recommendations are likely to mean more people being prescribed GLP-1 agonists like Mounjaro.